While surgeon and public health expert Dr. Atul Gawande thinks that the Biden administration has been hitting most of the marks when it comes to turning around the US vaccine rollout operation, there's one area where they need to step things up: the development of cheaper and more effective antiviral drugs for people infected with COVID-19. But when it comes to vaccine distribution itself, Dr. Gawande believes that the current administration has a firm grasp on boosting vaccine supply.
Ian Bremmer's Quick Take:
Hi everybody. Ian Bremmer here, and it is the last full day of the Trump administration. Extraordinary four years, unprecedented in so many ways. I guess the most important feature for me is how much more divided the United States is, the world is, as coming out of the Trump administration than it was coming in. Not new. We were in a GZERO world, as I called it well before Trump was elected president. The social contract was seen as fundamentally problematic. Many Americans believed their system was rigged, didn't want to play the kind of international leadership role that the United States had heretofore, but all of those things accelerated under Trump.
So perhaps the most important question to be answered is, once Trump is gone, how much of that persists? It is certainly true that a President Biden is much more oriented towards trying to bring the United States back into existing multilateral architecture, whether that be the Paris Climate Accord, or more normalized immigration discussions with the Mexicans, the World Health Organization, the Iranian Nuclear Deal, some of which will be easy to do, like Paris, some of which will be very challenging, like Iran. But nonetheless, all sounds like business as usual.
Subscribe to GZERO Media's newsletter: Signal
Donald Trump has finally admitted he needs a new job - but he's optimistic. After all, he didn't need real skills or experience to get his last position.
Watch more PUPPET REGIME here.